Medical Communications

It has been announced that I trial will begin in London offering the public GP consultations through their smartphone. The …

As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …

There has been a raft of changes at senior levels of GSK since Emma Walmsley took over the role from …

The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK …

GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …

Spare a thought for Kare Schultz, he agreed to take on the position of CEO at Teva at the start …

Just over two weeks ago, Tissue Regenix announced that its long-standing CEO, Antony Odell, would be leaving the company. It …

Topas Therapeutics, a German company focused on developing novel therapeutics to treat immune-mediated and autoimmune diseases, announced that it has …

Matt Fellows investigates how the first-ever CAR-T therapy approvals in the past months could mean the field of cancer treatment …

Figures released by NHS Scotland have revealed that the numbers of deaths from cancer are 67% higher in the poorest …

Dear Colleague,

October is almost over and Halloween is just around the corner, and it’s time for another run-down of the stories …

Back in May of this year, the NHS was hit by a cyber attack that severely impacted at least 34% …

John N Kapoor, the 74-year old founder of Insys Pharma, has been legally charged over his involvement in driving a …

Celgene posted its Q3 results and investors did not react well – shares plunged 16% immediately, after the biotech cut …